Product Description

Imbruvica 140 mg Capsule consists of the active ingredient Ibrutinib. It is indicated to treat blood cancers like mantle cell lymphoma, chronic lymphocytic leukemia and Waldenstrom’s macroglobulinemia in patients who have not responded adequately to previous therapies.Mantle cell lymphoma is a less common type of cancer that affects the lymph nodes. Waldenstrom’s macroglobulinemia is a rare tumor affecting the elderly and males and is characterized by high plasma viscosity. Chronic lymphocytic leukemia (CLL) is a type of cancer that affects the white blood cells (lymphocytes) and lymph nodes.

Ibrunat Capsule is taken in a dose as advised by the doctor. The duration of treatment varies on the basis of your response to treatment. Your doctor may get regular blood tests to check number of blood cells during treatment with this medicine. It is known to reduce the number of blood cells in your blood thereby, increasing the susceptibility to infections.  It may cause headache, diarrhea, and nausea as its side effects.Drink plenty of fluid to prevent dehydration. Inform your physician if you have diarrhea that does not go away.

How to use

Take this medicine in the dose and duration as advised by your doctor. Imbruvica Capsule may be taken with or without food, but it is better to take it at a fixed time.

Uses

Treatment of Blood cancer
Treatment of Mantle cell lymphoma

Side Effects

Serious:

• Bleeding problems
• Infections
• Decrease in blood cell counts
• Heart problems
• High BP
• Secondary cancer
• Tumor lysis syndrome
• Severe allergic reactions

Common:

• Nausea, vomiting, diarrhea
• Tiredness
• Muscle and bone pain
• Rash and bruising
• Mouth sores
• Pneumonia
• Fever, chills
• Breathlessness
• Constipation
• Dizziness
• Body pain
• Swollen ankles and feet

Storage

Store below 30℃